Form 4: CME Group Director Equity Transactions

William R. Shepard, a Director at CME Group Inc., reported transactions involving the acquisition of common stock, including grants and dividend reinvestments.

Summary

• William R. Shepard, a Director at CME Group Inc. (CME), reported several transactions on June 25, 2026.
• These transactions include the acquisition of 645 shares of Class A Common Stock at $225 per share and 422 shares at $225 per share.
• Additionally, 14.318 shares and 324.782 shares were acquired at $230.57 per share through a dividend reinvestment plan.
• Shepard's beneficial ownership following these transactions is 3,184.45 shares directly and 260,442.322 shares indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity compensation and dividend reinvestment transactions by a director, which are standard corporate practices and do not inherently signal positive or negative performance.

Positives

• Director William R. Shepard received a grant of fully vested shares of Class A Common Stock as part of the annual equity compensation program for non-employee directors.
• Shares were also acquired through a dividend reinvestment plan, indicating continued investment in the company.
• The transactions show an increase in beneficial ownership, both directly and indirectly.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and reflect typical compensation practices for non-employee directors in the financial services industry, such as equity grants and dividend reinvestment plans.

Stakeholder Impact

• Shareholders: The filing provides transparency into director compensation and ownership, which is a standard aspect of corporate governance and can influence investor confidence.

Key Dates

Keywords

CME Group, Form 4, Director, Equity Compensation, Common Stock, Beneficial Ownership, Dividend Reinvestment